Mustang Bio Inc expected to post a loss of $3.01 a share - Earnings Preview

Mustang Bio

09/05/2023 03:04

* Mustang Bio Inc  MBIO.OQ   MBIO.O  is expected to show no
change
in quarterly revenue when it reports  results on May 10
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Mustang Bio Inc is
for a
loss of $3.01 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 1.3%
in the last three months. ​
    * Wall Street's median 12-month price target for Mustang Bio
Inc
is $60​, above​ its last closing price of $4.22. ​​​

This summary was machine generated May 9 at 02:03 GMT.  All
figures in US dollars  unless otherwise stated